With the rapid pace and scale of the emerging coronavirus 2019 (COVID-19) pandemic, a
growing body of evidence has shown a strong association of COVID-19 with pre-and post …

While the epidemic of Coronavirus disease 2019 (COVID-19) continues to spread globally,
more and more evidences are collected about the presence of neurological manifestations …

Background Patients with chronic diseases likely develop severe 2019 coronavirus disease
(COVID-19). However, little is known about the effects of COVID-19 on patients with …

Background and purpose The recent SARS‐CoV‐2 pandemic has posed multiple
challenges to the practice of clinical neurology including recognition of emerging …

The magnitude of the COVID-19 pandemic will result in substantial neurological disease,
whether through direct infection (rare), para-infectious complications (less rare), or critical …

Objective The emergence of coronavirus disease 2019 (COVID-19) presents a challenge for
neurologists caring for patients with preexisting neurologic conditions hospitalized for …

Background The COVID-19 pandemic leads to disruptions of health services worldwide. To
evaluate the particular impact on neurological services a rapid review was conducted …

The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …

The neurological deficits caused by COVID-19, which were first reported in the early months
of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two …

SARS-CoV-2 is associated with new-onset neurological and psychiatric conditions. Detailed
clinical data, including factors associated with recovery, are lacking, hampering prediction …